KALA BIO, INC. Operating Lease, Weighted Average Discount Rate, Percent
KALA BIO, INC. (KALA) had Operating Lease, Weighted Average Discount Rate, Percent of 13.10% as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-04-15
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 13.10%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 13.10%.
- 2025-03-31: Operating Lease, Weighted Average Discount Rate, Percent 13.10%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 13.10%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-09-30 | 13.10% 10-Q · filed 2025-11-19 |
| 2025-06-30 | 13.10% 10-Q · filed 2025-08-08 |
| 2025-03-31 | 13.10% 10-Q · filed 2025-05-14 |
| 2024-12-31 | 13.10% 10-K · filed 2026-04-15 |
| 2024-09-30 | 13.10% 10-Q · filed 2024-11-12 |
| 2023-12-31 | 13.10% 10-K · filed 2025-03-31 |
| 2023-03-31 | 10.40% 10-Q · filed 2023-05-09 |
| 2022-12-31 | 10.40% 10-K · filed 2024-03-29 |
| 2022-09-30 | 10.30% 10-Q · filed 2022-11-08 |
| 2022-06-30 | 10.20% 10-Q · filed 2022-08-11 |
| 2022-03-31 | 2.20% 10-Q · filed 2022-05-16 |
| 2021-12-31 | 2.60% 10-K · filed 2023-03-03 |
| 2021-09-30 | 9.60% 10-Q · filed 2021-11-15 |
| 2021-06-30 | 9.60% 10-Q · filed 2021-08-05 |
| 2021-03-31 | 9.60% 10-Q · filed 2021-05-05 |
| 2020-12-31 | 9.80% 10-K · filed 2022-03-29 |
| 2018-09-30 | 6.50% 10-Q · filed 2018-11-08 |
| 2018-03-31 | 6.50% 10-Q · filed 2018-08-09 |
| 2017-12-31 | 6.50% 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |